KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Profit After Tax (2016 - 2025)

Thermo Fisher Scientific's Profit After Tax history spans 17 years, with the latest figure at $2.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Profit After Tax rose 6.72% year-over-year to $2.0 billion, compared with a TTM value of $6.7 billion through Dec 2025, up 5.66%, and an annual FY2025 reading of $6.7 billion, up 5.82% over the prior year.
  • Profit After Tax for Q4 2025 was $2.0 billion at Thermo Fisher Scientific, up from $1.6 billion in the prior quarter.
  • The five-year high for Profit After Tax was $2.3 billion in Q2 2021, with the low at $1.3 billion in Q2 2023.
  • Average Profit After Tax over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2024.
  • Year-over-year, Profit After Tax surged 196.57% in 2021 and then tumbled 41.8% in 2023.
  • Tracing TMO's Profit After Tax over 5 years: stood at $1.7 billion in 2021, then fell by 5.12% to $1.6 billion in 2022, then rose by 2.03% to $1.6 billion in 2023, then rose by 13.95% to $1.8 billion in 2024, then grew by 6.72% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Profit After Tax are $2.0 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025).